Symbol Name ID |
Igsf9
immunoglobulin superfamily, member 9 MGI:2135283 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Igsf9em1(IMPC)J/Igsf9em1(IMPC)J C57BL/6NJ-Igsf9em1(IMPC)J/Mmjax |
increased circulating creatinine level | J:211773 |
increased circulating phosphate level | J:211773 | |
Igsf9tm1Kln/Igsf9tm1Kln involves: 129P2/OlaHsd * C57BL/6 |
abnormal synapse morphology | J:209586 |
decreased miniature inhibitory postsynaptic current frequency | J:209586 | |
increased susceptibility to pharmacologically induced seizures | J:209586 | |
normal nervous system phenotype | J:133898, J:209586 | |
Igsf9tm1Kln/Igsf9tm1Kln involves: 129P2/OlaHsd * C57BL/6 * CD-1 |
no abnormal phenotype detected | J:133898 |
Igsf9tm2Kln/Igsf9tm2Kln involves: 129P2/OlaHsd * C57BL/6 |
no abnormal phenotype detected | J:209586 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/19/2024 MGI 6.24 |
|
|